Two-Dose Intranasal NSC-EV Therapy Reduced Aged Hippocampal Inflammation in Mice
TL;DR: A 2026 mouse study in Journal of Extracellular Vesicles found that two intranasal doses of hiPSC-NSC-EVs reduced inflammatory pathway markers in the aged hippocampus and were associated with better memory performance. Key Findings Two-dose nasal treatme…
Read article